Reactive oxygen species promote localized DNA damage in glaucoma-iris tissues of elderly patients vulnerable to diabetic injury

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 697, Issue 1-2, 2010, Pages 19-23

  Szaflik, Jacek P ^a   Rusin, Pawel ^b   Zaleska Zmijewska, Anna ^a   Kowalski, Michał ^a   Majsterek, Ireneusz ^b,c   Szaflik, Jerzy ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Comet assay; Diabetes mellitus; Glaucoma; Oxidative DNA damage

Indexed keywords

REACTIVE OXYGEN METABOLITE;

AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DNA DAMAGE; DNA STRAND BREAKAGE; FEMALE; GLAUCOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; COMET ASSAY; DIABETES MELLITUS, TYPE 2; DNA DAMAGE; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; IRIS; MALE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 77949491044     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.02.003     Document Type: Article

References (56)

1. Quigley H.A., and Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90 (2006) 262-267
2. Traverso C.E., Walt J.G., Kelly S.P., Hommer A.H., Bron A.M., Denis P., Nordmann J.P., Renard J.P., Bayer A., Grehn F., Pfeiffer N., Cedrone C., Gandolfi S., Orzalesi N., Nucci C., Rossetti L., Azuara-Blanco A., Bagnis A., Hitchings R., Salmon J.F., Bricola G., Buchholz P.M., Kotak S.V., Katz L.M., Siegartel L.R., and Doyle J.J. Direct costs of glaucoma and severity of the disease a multinational long term study of resource utilisation in Europe. Br. J. Ophthalmol. 89 (2005) 1245-1249
3. Chen P.P. Blindness in patients with treated open-angle glaucoma. Ophthalmology 110 (2003) 726-733
4. Bonovas S., Peponis V., and Filioussi K. Diabetes mellitus as a risk factor for primary open-angle glaucoma a meta-analysis. Diabet. Med. 21 (2004) 609-614
5. Dielemans I., de Jong P.T., Stolk R., Vingerling J.R., Grobbee D.E., and Hofman A. Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population: the Rotterdam Study. Ophthalmology 103 (1996) 1271-1275
6. Ellis J.D., Evans J.M., Ruta D.A., Baines P.S., Leese G., MacDonald T.M., and Morris A.D. Glaucoma incidence in an unselected cohort of diabetic patients is diabetes mellitus a risk factor for glaucoma?, DARTS/MEMO collaboration. Diabetes Audit and Research in Tayside Study. Medicines Monitoring Unit. Br. J. Ophthalmol. 84 (2000) 1218-1224
7. Klein B.E., Klein R., and Jensen S.C. Open-angle glaucoma and older-onset diabetes, The Beaver Dam Eye Study. Ophthalmology 101 (1994) 1173-1177
8. Mitchell P., Smith W., Chey T., and Healey P.R. Open-angle glaucoma and diabetes, The Blue Mountains eye study, Australia. Ophthalmology 104 (1997) 712-718
9. Pasquale L.R., Kang J.H., Manson J.E., Willett W., Rosner B., and Hankinson S. Prospective study of type 2 diabetes mellitus and primary open-angle glaucoma in women. Ophthalmology 113 (2006) 1081-1086
10. Ikram M.K., de Voogd S., Wolfs R.C., Hofman A., Breteler M.M., Hubbard L.D., and de Jong P.T. Retinal vessel diameters and incident open-angle glaucoma and optic disc changes: the Rotterdam study. Invest. Ophthalmol. Vis. Sci. 46 (2005) 1182-1187
11. Leske M.C., Wu S.Y., Honkanen R., Nemesure B., Schachat A., Hyman L., and Hennis A. Nine-year incidence of open-angle glaucoma in the Barbados Eye Studies. Barbados Eye Studies Group. Ophthalmology 114 (2007) 1058-1064
12. Wu S.Y., Nemesure B., Hennis A., Schachat A.P., Hyman L., and Leske M.C. Open-angle glaucoma and mortality: the Barbados Eye Studies. Barbados Eye Studies Group. Arch. Ophthalmol. 126 (2008) 365-370
13. Skyler J. Microvascular complications. Retinopathy and nephropathy. Endocrinol. Metab. Clin. North Am. 30 (2001) 833-856
14. Nathan D.M. Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study. Lancet 352 (1998) 832-833
15. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
16. Baynes J.W., and Thorpe S.R. Role of oxidative stress in diabetic complications a new perspective on an old paradigm. Diabetes 48 (1999) 1-9
17. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46 (1995) 223-234
18. Ido Y., Kilo C., and Williamson J.R. Cytosolic NADH/NAD+, free radicals, and vascular dysfunction in early diabetes mellitus. Diabetologia 40 (1997) 115-117
19. Pfeiffer A., and Schatz H. Diabetic microvascular complications and growth factors. Exp. Clin. Endocrinol. Diabetes 103 (1995) 7-14
20. Sharma K., and Ziyadeh F.N. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin. Nephrol. 17 (1997) 80-92
21. Semenkovich C.F., and Heinecke J.W. The mystery of diabetes and atherosclerosis time for a new plot. Diabetes 46 (1997) 327-334
22. Ishii H., Jirousek M.R., Koya D., Takagi C., Xia P., Clermont A., Bursell S.E., Kern T.S., Ballas L.M., Heath W.F., Stramm L.E., Feener E.P., and King G.L. Amelioration of vascular dysfunctions in diabetic rats by an oral PKCβ an inhibitor. Science 272 (1996) 728-731
23. Monnier V.M. Intervention against the Maillard reaction in vivo. Arch. Biochem. Biophys. 419 (2003) 1-15
24. Wells-Knecht K.J., Zyzak D.V., Litchfield J.E., Thorpe S.R., and Baynes J.W. Mechanism of autoxidative glycosylation identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34 (1995) 3702-3709
25. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 (2003) 5-20
26. Singh N.P., McCoy M.T., Tice R.R., and Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175 (1988) 184-191
27. Klaude M., Eriksson S., Nygren J., and Ahnstrom G. The comet assay mechanisms and technical considerations. Mutat. Res. 363 (1996) 89-96
28. Doetsch P.W., Henner W.D., Cunningham R.P., Toney J.H., and Helland D.E. A highly conserved endonuclease activity present in Escherichia coli, bovine, and human cells recognizes oxidative DNA damage at sites of pyrimidines. Mol. Cell. Biol. 7 (1987) 26-32
29. Charliat G., Jolly D., and Blanchard F. Genetic risk factor in primary open-angle glaucoma a case-control study. Ophthalmic Epidemiol. 1 (1994) 131-138
30. deVoogd S., Ikram M.K., Wolfs R.C., Jansonius N.M., Witteman J.C., Hofman A., and de Jong P.T. Is diabetes mellitus a risk factor for open-angle glaucoma? The Rotterdam Study. Ophthalmology 113 (2006) 1827-1831
31. Kiambo D.K., Buntinx F., and Missotten L. Risk factors for open-angle glaucoma a case-control study. J. Clin. Epidemiol. 54 (2001) 166-171
32. Quigley H.A., West S.K., Rodriguez J., Munoz B., Klein R., and Snyder R. The prevalence of glaucoma in a population-based study of Hispanic subjects Projecto VER. Arch. Ophthalmol. 119 (2001) 1819-1826
33. Tielsch J.M., Katz J., Quigley H.A., Javitt J.C., and Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 102 (1995) 48-53
34. Wormald R.P., Basauri E., Wright L.A., and Evans J.R. The African Caribbean Eye Survey risk factors for glaucoma in a sample of African Caribbean people living in London. Eye 8 (1994) 315-320
35. Wenzel P., Schuhmacher S., Kienhöfer J., Müller J., Hortmann M., Oelze M., Schulz E., Treiber N., Kawamoto T., Scharffetter-Kochanek K., Münzel T., Bürkle A., Bachschmid M.M., and Daiber A. Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction. Cardiovasc. Res. 80 (2008) 280-289
36. Sliwinska A., Blasiak J., Kasznicki J., and Drzewoski J. In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM). Chem. Biol. Interact. 173 (2008) 159-165
37. Majsterek I., Blasiak J., Hoser G., Slupianek A., and Skorski T. ABL-fusion oncoproteins activate multi-pathway of DNA repair role in drug resistance. Biochimie 86 (2004) 53-65
38. Brown M.F., and Stuart J.A. Correlation of mitochondrial superoxide dismutase and DNA polymerase beta in mammalian dermal fibroblasts with species maximal lifespan. Mech. Ageing Dev. 128 (2007) 696-705
39. Tiedge M., Lortz S., Drinkgern J., and Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defence status of insulin-producing cells. Diabetes 46 (1997) 1733-1742
40. Bandaru V., Sunkara S., Wallace S.S., and Bond J.P. A novel human DNA glycosylase that removes oxidative DNA damage and is homologous to Escherichia coli endonuclease VIII. DNA Repair 1 (2002) 517-529
41. Ocampo M.T.A., Chaung W., Marenstein D.R., Chan M.K., Altamirano A., Basu A.K., Boorstein R.J., Cunningham R.P., and Teebor G.W. Targeted deletion of mNth1 reveals a novel DNA repair enzyme activity. Mol. Cell. Biol. 22 (2002) 6111-6121
42. Gorbunova V., Seluanov A., Mao Z., and Hine C. Changes in DNA repair during aging. Nucleic Acids Res. 35 (2007) 7466-7474
43. Moriwaki S., and Takahashi Y. Photoaging and DNA repair. J. Dermatol. Sci. 50 (2008) 169-176
44. Xu G., Herzig M., Rotrekl V., and Walter C.A. Base excision repair, aging and health span. Mech. Ageing Dev. 129 (2008) 366-382
45. Lin T.L., and Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006) 787-795
46. Truscott R.J.W. Age-related nuclear cataract-oxidation is the key. Exp. Eye Res. 80 (2005) 709-725
47. Faschinger C., Schmut O., Wachswender C., and Mossböck G. Glaucoma and oxidative stress. Determination of malondialdehyde-a product of lipid peroxidation. Ophthalmology 103 (2006) 953-959
48. Tezel G. Oxidative stress in glaucomatous neurodegeneration mechanisms and consequences. Prog. Retin. Eye Res. 25 (2006) 490-513
49. Tezel G., Luo C., and Yang X. Accelerated aging in glaucoma immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest. Ophthalmol. Vis. Sci. 48 3 (2007) 1201-1211
50. Brennan L.A., and Kantorow M. Mitochondrial function and redox control in the aging eye Role of MsrA and other repair systems in cataract and macular degenerations. Exp. Eye Res. 88 (2009) 195-203
51. Hollyfield J.G., Bonilha V.L., Rayborn M.E., Yang X., Shadrach K.G., Lu L., Ufret R.L., Aalomen R.G., and Perez V.L. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 14 2 (2008) 194-198
52. Hegde K.R., and Varma S.D. Prevention of oxidative stress to the retina by pyruvate. A preliminary report. Ophthalmologica 222 (2008) 194-198
53. Saccà S.C., Pascotto A., Camicione P., Capris P., and Izzotti A. Oxidative DNA damage in the human trabecular meshwork clinical correlation in patients with primary open-angle glaucoma. Arch. Ophthalmol. 123 4 (2005) 458-463
54. Rosen P., Nawroth P.P., King G., Moller W., Tritschler H.J., and Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab. Res. Rev. 17 (2001) 189-212
55. Merzouk S., Hichami A., Madani S., Merzouk H., Berouiguet A.Y., Prost J., Moutariou K., Chabane-Sari N., and Khan N.A. Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications. Gen. Physiol. Biophys. 22 (2003) 15-27
56. Huang L., Yappert M.C., Jumblatt M.M., and Borchman D. Hyperoxia and thyroxine treatment and the relationships between reactive oxygen species generation, mitochondrial membrane potential, and cardiolipin in human lens epithelial cell cultures. Curr. Eye Res. 33 (2008) 575-586